These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 3549583

  • 1. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P, Sahai J, Wahi PL, Sharma BK, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [Abstract] [Full Text] [Related]

  • 2. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P, Sethi V, Sharma BK, Wahl PL, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [Abstract] [Full Text] [Related]

  • 3. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH.
    Ann Clin Res; 1981 Nov; 13 Suppl 30():23-9. PubMed ID: 7027890
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S, Alaimo G, Giordano U, Raineri A, Strano A.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [Abstract] [Full Text] [Related]

  • 5. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H.
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [Abstract] [Full Text] [Related]

  • 7. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Apr; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 8. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Apr; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA, Tooley M, Sibbald B, Gould SE.
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [Abstract] [Full Text] [Related]

  • 10. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ, Lindner PC.
    Ann Clin Res; 1981 Apr; 13 Suppl 30():61-7. PubMed ID: 6794420
    [Abstract] [Full Text] [Related]

  • 11. [The effects of captopril and metoprolol on blood pressure and side effects in patients with mild to moderate hypertension].
    Kornerup HJ, Korsager S.
    Ugeskr Laeger; 1989 Apr 03; 151(14):890-2. PubMed ID: 2652842
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B, Hansson L.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 03; 20(6):291-5. PubMed ID: 7049966
    [Abstract] [Full Text] [Related]

  • 13. A randomized double-blind clinical trial of xipamid and hydrochlorothiazide in essential hypertension.
    Kumar S, Pandhi P, Wahi PL, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct 03; 22(10):549-51. PubMed ID: 6392119
    [Abstract] [Full Text] [Related]

  • 14. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA, Simmons RL, Ward PJ, Chester PC, Latham AN.
    J Hum Hypertens; 1988 Mar 03; 1(4):305-10. PubMed ID: 3065507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ, Armstrong BK, Nassim MA, Beilin LJ.
    Br J Clin Pharmacol; 1976 Aug 03; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [Abstract] [Full Text] [Related]

  • 17. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL, Goldstraw PW, Kiddle GB, Flacks LM, Watt M.
    N Z Med J; 1981 Jul 08; 93(687):1-2. PubMed ID: 7022275
    [Abstract] [Full Text] [Related]

  • 18. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P, Aslam S, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb 08; 23(2):101-4. PubMed ID: 3886563
    [Abstract] [Full Text] [Related]

  • 19. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD, Mullane JF.
    Clin Ther; 1982 Feb 08; 4(6):497-509. PubMed ID: 7046937
    [Abstract] [Full Text] [Related]

  • 20. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD, Hesse CJ.
    Ann Clin Res; 1981 Feb 08; 13 Suppl 30():16-22. PubMed ID: 7027889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.